Common Stock, Shares, Issued of BioNexus Gene Lab Corp from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
BioNexus Gene Lab Corp quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • BioNexus Gene Lab Corp Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 1,796,597.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

BioNexus Gene Lab Corp Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,796,597 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 1,796,597 30 Jun 2025 10-Q 18 Aug 2025 2025 Q2
Q4 2024 1,796,766 -15,870,897 -90% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q4 2023 17,667,663 +3,191,150 +22% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q2 2023 173,718,152 +2,500,000 +1.5% 30 Jun 2023 10-Q 16 Aug 2023 2023 Q2
Q1 2023 173,718,152 +2,500,000 +1.5% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 14,476,513 -156,741,639 -92% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 173,718,152 +2,500,000 +1.5% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 171,218,152 0 0% 30 Jun 2022 10-Q 16 Aug 2023 2023 Q2
Q1 2022 171,218,152 0 0% 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 171,218,152 0 0% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 171,218,152 +68,487,261 +67% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 171,218,152 +68,487,261 +67% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 171,218,152 +68,487,261 +67% 31 Mar 2021 10-Q 18 May 2021 2021 Q1
Q4 2020 171,218,152 +68,487,261 +67% 31 Dec 2020 10-K 06 Apr 2022 2021 FY
Q3 2020 102,730,891 +29,033,333 +39% 30 Sep 2020 10-Q/A 09 Nov 2020 2020 Q3
Q2 2020 102,730,891 +28,103,333 +38% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 102,730,891 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 102,730,891 +28,103,333 +38% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 73,697,558 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 74,627,558 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q4 2018 74,627,558 31 Dec 2018 10-K 31 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.